Last $40.84 USD
Change Today -0.41 / -0.99%
Volume 313.2K
NEOG On Other Exchanges
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

neogen corp (NEOG) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/10/13 - $51.22
52 Week Low
05/15/14 - $35.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEOGEN CORP (NEOG)

Related News

No related news articles were found.

neogen corp (NEOG) Related Businessweek News

No Related Businessweek News Found

neogen corp (NEOG) Details

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products and services for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug and pesticide residues, and general sanitation concerns; and AccuPoint rapid sanitation test for adenosine triphosphate, a chemical found in living cells. It offers its products primarily to food and feed processors, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, and dairies; laboratories; producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various regulatory agencies. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. This segment’s drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, this segment offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

926 Employees
Last Reported Date: 07/30/14
Founded in 1981

neogen corp (NEOG) Top Compensated Officers

Chairman, Chief Executive Officer, Interim Pr...
Total Annual Compensation: $532.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $233.0K
Vice President of Animal Safety Operations
Total Annual Compensation: $213.0K
Vice President of Food Safety Operations
Total Annual Compensation: $194.0K
Total Annual Compensation: $257.8K
Compensation as of Fiscal Year 2014.

neogen corp (NEOG) Key Developments

Neogen Signs Igenity Dairy Heifer Programme Marketing Agreement with Merck Animal Health

Neogen announced that it has signed a strategic agreement to market its Igenity Dairy Heifer Programme through Merck Animal Health. Under the agreement, Merck Animal Health will market Neogen's Igenity-Prime, the original test available to determine the genetic merit of a commercial dairy heifer as well as the Igenity-Select, an decision-making tool for commercial dairies that features nearly 7,000 genetic markers for disease and performance traits.

Neogen Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended May 31, 2014

Neogen Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended May 31, 2014. For the quarter, the company's total revenue was $67,262,000 compared to $56,006,000 a year ago. Operating income was $10,991,000 compared to $10,235,000 a year ago. Income before tax was $11,154,000 compared to $10,127,000 a year ago. Net income was $7,554,000 compared to $6,977,000 a year ago. Net income attributable to the company was $7,537,000 or $0.20 per diluted share compared to $7,032,000 or $0.19 per diluted share a year ago. For the year, the company's total revenue was $247,405,000 compared to $207,528,000 a year ago. Operating income was $43,391,000 compared to $40,706,000 a year ago. Income before tax was $43,031,000 compared to $41,141,000 a year ago. Net income was $28,031,000 compared to $27,041,000 a year ago. Net income attributable to the company was $28,158,000 or $0.76 per diluted share compared to $27,190,000 or $0.75 per diluted share a year ago.

Neogen Mulls Acquisitions

Neogen Corp. (NasdaqGS:NEOG) is looking for acquisitions. Chief Executive Officer, Jim Herbert stated, “The opportunities in China will be even bigger, as we look over for the next year as to what we might be doing there. It will be a challenge for us to keep up with that growth I think as we expand our China operations, both the market share increases, as well as some possibilities of some acquisitions there.” The official added, “We continue to expand our staff in most all of the critical area. As Steve mentioned, our balance sheet is strong with cash now over $76 million and no borrowing. There are several interesting acquisition opportunities that are on the radar, though, we don't currently have any Letters of Intent in place. I think we've learned that even though we've done 26 well-positioned acquisitions since the year 2000, we still don't take it for granted that every acquisition would be a fit for our mission.”


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEOG:US $40.84 USD -0.41

NEOG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biomerica Inc $0.83 USD 0.00
Meridian Bioscience Inc $18.24 USD -0.47
OraSure Technologies Inc $7.73 USD +0.10
Roka Bioscience Inc $9.52 USD -0.46
Trinity Biotech PLC $20.14 USD -0.10
View Industry Companies

Industry Analysis


Industry Average

Valuation NEOG Industry Range
Price/Earnings 54.1x
Price/Sales 6.2x
Price/Book 4.9x
Price/Cash Flow 53.3x
TEV/Sales 5.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGEN CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at